General Session
Reversing Chemoresistance in Platinum-Resistant Ovarian Cancer: The Role of Glucocorticoid-Receptor Modulation and Other Emerging Therapeutic Pathways
45 min
Sunday, March 15, 2026
10:25 AM - 11:10 AM
Supported by an educational grant from Corcept Therapeutics, Inc.
-
Presenter
-
-
Room
- Royal Ballroom 3/4